首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   9231篇
  免费   441篇
  国内免费   14篇
林业   588篇
农学   229篇
基础科学   84篇
  1585篇
综合类   1610篇
农作物   360篇
水产渔业   818篇
畜牧兽医   3366篇
园艺   278篇
植物保护   768篇
  2023年   59篇
  2022年   82篇
  2021年   154篇
  2020年   211篇
  2019年   208篇
  2018年   206篇
  2017年   218篇
  2016年   210篇
  2015年   184篇
  2014年   252篇
  2013年   449篇
  2012年   542篇
  2011年   707篇
  2010年   368篇
  2009年   352篇
  2008年   635篇
  2007年   623篇
  2006年   592篇
  2005年   574篇
  2004年   608篇
  2003年   571篇
  2002年   504篇
  2001年   98篇
  2000年   90篇
  1999年   93篇
  1998年   81篇
  1997年   70篇
  1996年   67篇
  1995年   62篇
  1994年   61篇
  1993年   50篇
  1992年   57篇
  1991年   49篇
  1990年   58篇
  1989年   49篇
  1988年   42篇
  1987年   44篇
  1986年   33篇
  1985年   32篇
  1984年   34篇
  1983年   40篇
  1982年   26篇
  1981年   25篇
  1980年   28篇
  1979年   23篇
  1978年   20篇
  1977年   15篇
  1976年   20篇
  1975年   22篇
  1974年   15篇
排序方式: 共有9686条查询结果,搜索用时 31 毫秒
991.
992.
993.
994.
995.
996.
997.
998.
999.
OBJECTIVE: To determine effects of atracurium on intraocular pressure (IOP), eye position, and arterial blood pressure in eucapnic and hypocapnic dogs anesthetized with isoflurane. ANIMALS: 16 dogs. PROCEDURE: Ventilation during anesthesia was controlled to maintain Paco2 at 38 to 44 mm Hg in group- I dogs (n = 8) and 26 to 32 mm Hg in group-II dogs (8). Baseline measurements for IOP, systolic, diastolic, and mean arterial blood pressure, central venous pressure (CVP), and heart rate (HR) were recorded. Responses to peroneal nerve stimulation were monitored by use of a force-displacement transducer. Atracurium (0.2 mg/kg) was administered i.v. and measurements were repeated at 1, 2, 3, and 5 minutes and at 5-minute intervals thereafter for 60 minutes. RESULTS: Atracurium did not affect IOP, HR, or CVP Group II had higher CVP than group I, but IOP was not different. There was no immediate effect of atracurium on arterial blood pressure. Arterial blood pressure increased gradually over time in both groups. Thirty seconds after administration of atracurium, the eye rotated from a ventromedial position to a central position and remained centrally positioned until 100% recovery of a train-of-four twitch response. The time to 100% recovery was 53.1 +/- 5.3 minutes for group I and 46.3 +/- 9.2 minutes for group II. CONCLUSIONS AND CLINICAL RELEVANCE: Atracurium did not affect IOP or arterial blood pressure in isoflurane-anesthetized dogs. Hyperventilation did not affect IOP or the duration of effect of atracurium.  相似文献   
1000.
OBJECTIVE: To measure changes in the modulus of elasticity (E) and describe histologic findings after extracorporeal shock wave therapy and radial pressure wave therapy on equine cortical bone specimens. SAMPLE POPULATION: 16 bone specimens from the proximodorsal cortex of an equine third metacarpal or metatarsal bone. PROCEDURE: Baseline E was determined by the density (p) and unidirectional ultrasound transmission velocity (C) of each specimen according to the equation E = pC2. Eight specimens were treated with 500 pulses of 0.15 mJ/mm2 of extracorporeal shock wave therapy, and 8 specimens were treated with 500 pulses of 0.16 mJ/mm2of radial pressure wave therapy. After treatment, C was determined again. Four treatment sessions resulted in 2,000 pulses and 5 C measurements. The p of each sample was measured again. Mean post-treatment E was calculated for each group. Nondecalcified sections of all specimens were stained with toluidine blue or basic fuchsin for histologic evaluation. RESULTS: Overall treatment group effect was not significant for C or E. Final E was not different from baseline values for extracorporeal shock wave therapy and radial pressure wave therapy. No histologic changes could be attributed to either treatment modality. CONCLUSIONS AND CLINICAL RELEVANCE: Extracorporeal shock wave therapy and radial pressure wave therapy did not affect the material properties of equine bone at the energy and pulse values used in this study.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号